Skip to content
10-K

Annual Report

ANIXA BIOSCIENCES, INC. ANIX

0001493152-25-001787

← back to feed
Filed
Jan 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 10, 2025 32.2M sh
Stock Repurchased FY 2024 · Oct 31, 2024 $6K
Shares Diluted FY 2024 · Oct 31, 2023 30.98K sh
Operating Cash Flow FY 2024 · Oct 31, 2023 −$6.21M
Short Term Investments FY 2024 · Oct 31, 2023 $22.93M
Cash And Equivalents FY 2024 · Oct 31, 2023 $915K
Stockholders Equity FY 2024 · Oct 31, 2023 $24.34M
Current Liabilities FY 2024 · Oct 31, 2023 $2.03M
Total Liabilities FY 2024 · Oct 31, 2023 $2.15M
Current Assets FY 2024 · Oct 31, 2023 $25.36M
Total Assets FY 2024 · Oct 31, 2023 $25.52M
Eps Diluted restated FY 2024 · Oct 31, 2023 −$0.32
Eps Basic restated FY 2024 · Oct 31, 2023 −$0.32
Rd Expense FY 2024 · Oct 31, 2023 $4.77M
Net Income FY 2024 · Oct 31, 2023 −$9.81M
Operating Income FY 2024 · Oct 31, 2023 −$11.01M
Revenue FY 2024 · Oct 31, 2023 $210K